First human trials of designer protein therapies stun US neuroscientists
“Stunned silence.” That’s how Bryan Roth of the University of North Carolina School of Medicine described the…
UConn-made protein supplement is being studied. What it’s for.
A six-month study on an amino-acid supplement shake developed by UConn School of Medicine researchers for Parkinson’s patients…
Early warning signs, hidden risks, and habits that may slow its progression
Parkinson’s is a chronic condition that affects how the brain controls movement. It begins when nerve cells stop…
A CT man with a life-altering disease is first in clinical trial
A Connecticut resident was diagnosed with a life-altering disease almost a year ago and while waiting to be…
‘We were astonished by the success’
By Anna Shvets Groundbreaking research by the University of Sydney has identified a new brain protein involved in…
Disturbing link between Parkinson’s disease and living beside a golf club revealed by new study
LIVING near a golf course might come with more than just scenic views – it could carry a…